Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SKYLA vs SOLIFENACIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SKYLA vs SOLIFENACIN: Safety Overview

Metric SKYLA SOLIFENACIN
Total FAERS Reports 106 8,324
Deaths Reported 0 206
Death Rate N/A 2.5%
Hospitalizations 1 1,201
Average Patient Age 25.5 yrs 68.9 yrs
% Female Patients N/A 68.1%
FDA Approval Date N/A Apr 13, 2020
Manufacturer N/A Ajanta Pharma USA Inc.
Route N/A ORAL
Marketing Status N/A Discontinued